A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer (Q36610441)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 April 2007
edit
Language Label Description Also known as
English
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
scientific article published on 10 April 2007

    Statements

    A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit